Trials / Completed
CompletedNCT02640235
Effectiveness and Safety of CELSTAT for Hemostasis in Intraoperative Tissue Bleeding
A Prospective, Randomized, Controlled Study to Evaluate the Effectiveness and Safety of CELSTAT as an Adjunct to Hemostasis for Tissue Bleeding in Cardiothoracic, General, and Vascular Surgery.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 260 (actual)
- Sponsor
- Baxter Healthcare Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study is to evaluate the effectiveness and safety of CELSTAT vs active control.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CELSTAT | |
| DEVICE | Surgicel Original |
Timeline
- Start date
- 2016-02-24
- Primary completion
- 2017-07-21
- Completion
- 2017-10-18
- First posted
- 2015-12-28
- Last updated
- 2020-08-03
- Results posted
- 2020-08-03
Locations
25 sites across 4 countries: United States, Czechia, Germany, Poland
Source: ClinicalTrials.gov record NCT02640235. Inclusion in this directory is not an endorsement.